Molecular regulation of cervical cancer growth and invasion by VEGFa

Tumor Biology

Volumn 35, Issue 11, 2014, Pages 11587-11593

  Chen, Baohuan ^a   Zhang, Chunxiao ^a   Dong, Pingping ^a   Guo, Yuanying ^b   Mu, Nan ^c  

^a YANTAISHAN HOSPITAL   (China)

^b JILIN UNIVERSITY   (China)

^c YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

Akt; Cancer growth and invasion; Cervical cancer; mTor; PI3k; Vascular endothelial growth factor a

Indexed keywords

MESSENGER RNA; MTOR PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

APOPTOSIS; CELL MOTION; CELL PROLIFERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE; TUMOR INVASION; UTERINE CERVIX TUMOR; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84927797582     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2463-2     Document Type: Article

References (22)

1. Delli Carpini J, Karam AK, Montgomery L. Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer. Angiogenesis. 2010;13:43–58.
2. del Campo JM, Prat A, Gil-Moreno A, Perez J, Parera M. Update on novel therapeutic agents for cervical cancer. Gynecol Oncol. 2008;110:S72–6.
3. Zagouri F, Sergentanis TN, Chrysikos D, Filipits M, Bartsch R. Molecularly targeted therapies in cervical cancer. A systematic review. Gynecol Oncol. 2012;126:291–303.
4. Kim JG. Molecular targeted therapy for advanced gastric cancer. Korean J Intern Med. 2013;28:149–55.
5. Ilson DH. Angiogenesis in gastric cancer: hitting the target? Lancet. 2014;383:4–6.
6. Scartozzi M, Giampieri R, Loretelli C, Bittoni A, Mandolesi A, Faloppi L, et al. Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. Pharmacogenomics. 2013;14:1991–8.
7. Xiao X, Prasadan K, Guo P, El-Gohary Y, Fischbach S, Wiersch J, et al. Pancreatic duct cells as a source of VEGF in mice. Diabetologia. 2014;57:991–1000.
8. Bagri A, Kouros-Mehr H, Leong KG, Plowman GD. Use of anti-vegf adjuvant therapy in cancer: challenges and rationale. Trends Mol Med. 2010;16:122–32.
9. Xiao X, Guo P, Chen Z, El-Gohary Y, Wiersch J, Gaffar I, et al. Hypoglycemia reduces vascular endothelial growth factor a production by pancreatic beta cells as a regulator of beta cell mass. J Biol Chem. 2013;288:8636–46.
10. Ferrara N. Vascular endothelial growth factor. Arterioscler Thromb Vasc Biol. 2009;29:789–91.
11. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473:298–307.
12. Davidson B, Reich R, Risberg B, Nesland JM. The biological role and regulation of matrix metalloproteinases (mmp) in cancer. Arkh Patol. 2002;64:47–53.
13. Rhee JS, Coussens LM. Recking mmp function: Implications for cancer development. Trends Cell Biol. 2002;12:209–11.
14. Mitra A, Chakrabarti J, Chattopadhyay N, Chatterjee A. Membrane-associated mmp-2 in human cervical cancer. J Environ Pathol Toxicol Oncol Off Organ Int Soc Environ Toxicol Cancer. 2003;22:93–100.
15. Thompson EW, Yu M, Bueno J, Jin L, Maiti SN, Palao-Marco FL, et al. Collagen induced mmp-2 activation in human breast cancer. Breast Cancer Res Treat. 1994;31:357–70.
16. Harashima H, Dissmeyer N, Schnittger A. Cell cycle control across the eukaryotic kingdom. Trends Cell Biol. 2013;23:345–56.
17. Diaz-Moralli S, Tarrado-Castellarnau M, Miranda A, Cascante M. Targeting cell cycle regulation in cancer therapy. Pharmacol Ther. 2013;138:255–71.
18. Bertoli C, Skotheim JM, de Bruin RA. Control of cell cycle transcription during g1 and s phases. Nat Rev Mol Cell Biol. 2013;14:518–28.
19. Lim S, Kaldis P. Cdks, cyclins and ckis: roles beyond cell cycle regulation. Development. 2013;140:3079–93.
20. Xiao X, Gaffar I, Guo P, Wiersch J, Fischbach S, Peirish L, et al. M2 macrophages promote beta-cell proliferation by up-regulation of smad7. Proc Natl Acad Sci U S A. 2014;111:E1211–20.
21. Wang YQ, Guo X, Qiu MH, Feng XY, Sun FY. Vegf overexpression enhances striatal neurogenesis in brain of adult rat after a transient middle cerebral artery occlusion. J Neurosci Res. 2007;85:73–82.
22. Biggs 3rd WH, Meisenhelder J, Hunter T, Cavenee WK, Arden KC. Protein kinase b/akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor fkhr1. Proc Natl Acad Sci U S A. 1999;96:7421–6.